Bryan Johnson spent $2 million this year reversing his skin age by 9 years—then called sleep his #1 longevity drug, free for everyone.
No breaking news today in longevity science, but these timeless reads from the archives cut through the hype. Here's what's worth rereading.
Biohackers Are Ditching TB-500 After Cancer Warnings Hit Home
A Reddit biohacker stared at his stack of vials, TB-500 front and center for tendon repair and inflammation control. He'd been injecting it weekly, chasing faster recovery from workouts, inspired by whispers in the community about its healing powers from horse racing circles.
Then fresh research dropped: TB-500, a synthetic version of a thymus protein, ramps up cell migration and angiogenesis—great for wounds, risky for tumors. Studies linked it to promoting cancer growth in mice, with one paper showing it boosted metastasis in lung cancer models. Users reported sides like headaches and fatigue; now forums buzz with dropouts, swapping it for safer peptides or plain rest. The kicker? Human trials are zilch, leaving it in gray-market limbo.
One guy quit cold after a blood panel showed elevated markers—he's back to baseline in weeks.
Gobble's Take: Ditch the untested injectables now; your tendons heal fine without feeding potential cancers.
Source: r/biohacking
Gut Tests Promise Longevity Hacks—But Your Poop Isn't a Crystal Ball Yet
Dr. Christin Glorioso, MD PhD, sifted through a patient's stool report: "Low diversity, high bad bugs—fix with this probiotic." The patient, a 45-year-old exec chasing 100, shelled out $300 expecting a roadmap to beat aging.
Reality check: microbiome science exploded with 100+ companies selling kits linking gut bugs to brain fog, weight gain, even lifespan. Diversity scores correlate with health in big studies—think 10,000-person cohorts showing diverse guts slash inflammation 20%. Interventions like fiber blasts or fecal transplants show promise in trials, bumping good bacteria 30% and trimming waistlines. But gaps loom: one test says "eat kimchi," another "ditch dairy"—results vary wildly by lab methods, and causation? Still fuzzy.
Glorioso's verdict: test if curious, but prioritize real food over $500 poop guesses.
Gobble's Take: Test your gut if you want data, but fermented veggies beat any kit for your wallet and waistline.
Source: Dr. Glorioso Substack
Two Anti-Aging Leaps: Yeast Tricks That Might Add Your Lost Decades
Afshine pored over lab notes from a yeast colony outliving normals by 80%—thanks to tweaking cGAS, a DNA sensor that screams "damage!" and triggers inflammation. In naked mole rats, a mutated version chills it out, explaining their cancer-free 30-year runs.
Fast-forward: human cells dosed with cGAS inhibitors halved senescence markers; mouse trials slashed frailty scores 40%. Pair it with Rapalink-1, a TOR pathway tuner—yeast lived 82% longer, mammals got metabolic boosts without side effects. Stack with fasting? Lifespan models predict +15 years. But yeast-to-human jumps fail 90% of the time; mammalian recalibration starts now.
The combo's no fantasy—it's your future protocol if trials pan out.
Gobble's Take: Fast today while waiting for these pills; mole rat genes say suppress inflammation to steal their immortality.
Sources: Afshine Substack · Time Magazine
Senolytics Decode Zombie Cells—Pharma's $1B Bet on Your Second Youth
Faisal watched a diabetic patient's kidney biopsy: senescent "zombie" cells clogging tissues, spewing toxins that age everything 2x faster. Dasatinib plus quercetin cleared 35% in early human trials, easing fibrosis where standard drugs flopped.
Now the breakthrough: low-dose pulses zap zombies without toxicity—pulmonary fibrosis patients breathed 20% better after three months. Pair with NAD+ boosters (levels crash 50% by 50), and cells recharge like new batteries, spiking energy 25% in pilots. Not supplements yet—pharma-grade, $10k/course—but generics loom. Trials for kidney disease hit phase 2; skin rejuvenation next.
Your wrinkles and fatigue? Zombie eviction in progress.
Gobble's Take: Zombie cells steal your vitality—pop quercetin daily as a cheap preview till docs prescribe the real zapper.
Source: Faisal Substack
mTOR vs. AMPK: Flip the Switch, Unlock 20 Extra Years
William H. Bestermann Jr., MD, mapped a 60-year-old's bloodwork: sky-high mTOR from junk food and stress, crushing AMPK repair crews. Result? Accelerated rot at 1.5x normal speed.
The synergy: hit mTOR with rapamycin mimics (growth off), amp AMPK via exercise—trials show 25% lifespan extension in mice. Insulin spikes kill it; one meal-free day flips the switch, slashing inflammation 40%. Bryan Johnson lives this: his epigenetic age at 0.48, telomeres of a 12-year-old, by stacking basics first.
Integrated therapy isn't theory—it's the stack that beats solo hacks.
Gobble's Take: Skip meals to flip your survival switch; Johnson's teen biomarkers prove it trumps any pill alone.
Source: Bestermann Substack
In Case You Missed It
Yesterday's top stories:
- After 20 Years and Hundreds of Compounds, One Drug Keeps Winning: Rapamycin
- Two Cheap Amino Acids Matched Rapamycin's Best Results — and Also Fixed the Mice's Skin
- Scientists Have Named 12 Reasons You Age — and They're Building a Drug for Each One
- Bryan Johnson Spends $2M a Year on 11 Numbers — Here's the One That Matters Most
Get Longevity Lab in your inbox
Free daily briefing. No spam. Unsubscribe anytime.
